Skip to main content
Equibles

MDXH · MDxHealth SA

Track MDXH — free

Use MDXH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDXH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.70 +0.03 (+4.23%) At close · Sep 11
Rebalance outlook locked
Market Cap
$67.23M
Shares
95.42M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.70 Open$0.67 Day$0.66–0.71 52W close$0.40–5.00 Avg vol 30d11.9M Short int1.5M · 1.6% float · 1.0d Short vol24% Last earningsMar 31, 2026 DataNov 2021–Sep 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+19.8%
Year over year
Operating margin
-13.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.8%
Year over year · more shares
Price change (1Y)
-80.6%
Trailing year
Short interest
1.6%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −66%
below
Price vs 50-day avg +26%
above
RSI (14) 55
neutral
MACD trend Negative
52-week position 7%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +53%
trailing
6-month return −78%
trailing
YTD return −80%
this year
Relative strength −96%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1000.0K over 90 days · 0% sells
Short interest Rising
1.61% of float · ▲ +5.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
26 holders — mid 2-yr range
Squeeze score 40
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 113%
annualized · 1-yr
Max drawdown −92%
past year
ATR 8.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−66% Bearish
Price vs 50-day avg
+26% Bullish
RSI (14)
55 Neutral
MACD trend
Negative Bearish
52-week position
7% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1000.0K over 90 days · 0% sells
Short interest Rising
1.61% of float · ▲ +5.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
26 holders — mid 2-yr range
Price context
position in its 52-week range
Range low $0 Now $1 · 7% Range high $5
vs 200-day avg -66% vs 50-day avg +26%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Diagnostics & Research — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MDXH
MDxHealth SA
this stock
$67.23M -80.3% — — 1.6%
TMO
Thermo Fisher Scientific Inc.
 $225.48B +5.2% +14.5% 32.8 1.5%
DHR
Danaher Corp /De/
 $140.70B -12.6% +8.5% 35.5 1.4%
NTRA
Natera, Inc.
 $47.41B +43.6% -2.8% — 3.8%
IQV
Iqvia Holdings Inc.
 $43.69B +16.1% +41.6% 32.5 2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
26
% held
17.4%
Net QoQ
-132.5M sh
Top holder
Bleichroeder LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
1.5M
Days to cover
1.0d
Change
+81.5K sh
View
Short Volume
Short vol %
24%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
117.4K
Value
$54.0K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
58.7%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$1000.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 3, 2026
This year
11
View
Exempt Offerings
Offering
Indefinite
Filed
Aug 15, 2022
View
Earnings & Events
Earnings Calls
Last call
Mar 31, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
MDXH -3.0% +52.5% -77.7% -2.1% -80.3%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -1.8% +54.3% -95.5% -1.8% -92.3%
Key facts CIK 1872529 CUSIP B5950S113 13F (30d) 14 filings 14 filers Visit website